Clear Search
·
2 MIN READ

Physicians confront the rise of “smart drugs”

Safety concerns generated by a growing use of nootropics prompted the AMA to adopt new policy discouraging the nonmedical use of these prescription drugs for cognitive enhancement in healthy individuals.

Public Health
·
2 MIN READ

AMA confronts the rise of nootropics

Responding to the growing personal use of nootropics, AMA physicians today adopted policy to discourage nonmedical use of drugs for cognitive enhancement.

Press Releases
National Advocacy Conference panel
·
5 MIN READ

Experts explain high drug prices, offer solutions

Addressing the rising cost of prescription drugs, 3 experts in the pharmaceuticals field discuss marketplace trends affecting drug spending and pricing. They also discuss solutions to address drug prices and availability.

Public Health
·
5 MIN READ

Top 9 issues that will affect physicians in 2016

The AMA identified 9 top developments in health care regulations, legislation and insurance to watch in 2016. Included are: Medicare reforms, provider networks, and graduate medical education funding.

Payment & Delivery Models
·
3 MIN READ

From Rx prices to EHRs: Top stories from the 2015 AMA Interim Meeting

The 2015 AMA Interim Meeting took place this week. Read these highlights from the meeting, and see AMA Wire's® full coverage of the event to learn more.

Interim Meeting
·
4 MIN READ

Physicians call for fairness in drug prices, availability

In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs.

Public Health
·
5 MIN READ

CDC panel shares solutions to combat antibiotic resistance

The Centers for Disease Control and Prevention (CDC) estimates that 2 million U.S. illnesses and 23,000 deaths each year are caused by antibiotic-resistant infections, and these result in an estimated $20 billion in excess health care costs.

Public Health
·
3 MIN READ

AMA calls for ban on DTC ads of prescription drugs and medical devices

Physicians at the AMA Interim Meeting adopted new policy aimed at driving solutions to make prescription drugs more affordable.

Press Releases
·
3 MIN READ

AMA continues efforts to combat antibiotic resistance

The AMA today adopted policy during its Interim Meeting to help combat the spread of antibiotic resistant bacteria in all health care facilities.

Press Releases